Literature DB >> 22239875

Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease.

Andrew J Skalsky1, Jay J Han, Richard T Abresch, Craig M McDonald.   

Abstract

Dual-energy x-ray absorptiometry (DEXA) is a safe, noninvasive, inexpensive tool for managing patients with neuromuscular diseases. Regional and whole-body DEXA can be used to guide clinical treatments, such as determining body composition to guide nutritional recommendations, as well as to monitor disease progression by assessing regional and whole-body lean tissue mass. DEXA can also be used as an outcome measure for clinical trials.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22239875     DOI: 10.1016/j.pmr.2011.11.007

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  2 in total

Review 1.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.

Authors:  Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

2.  Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.

Authors:  Valeria A Sansone; James Burge; Michael P McDermott; Patty C Smith; Barbara Herr; Rabi Tawil; Shree Pandya; John Kissel; Emma Ciafaloni; Perry Shieh; Jeffrey W Ralph; Antony Amato; Steve C Cannon; Jaya Trivedi; Richard Barohn; Brian Crum; Hiroshi Mitsumoto; Alan Pestronk; Giovanni Meola; Robin Conwit; Michael G Hanna; Robert C Griggs
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.